These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 333699)

  • 1. Hepatitis B antigen infection and graft survival in cadaveric renal transplantation.
    Rashid A; Sengar DP; Couture RA; Jindal S; Posen G
    Trans Am Soc Artif Intern Organs; 1977; 23():433-6. PubMed ID: 333699
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B surface antigenemia in renal transplant recipients. Increased mortality risk.
    Hillis WD; Hillis A; Walker WG
    JAMA; 1979 Jul; 242(4):329-32. PubMed ID: 376886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft survival and response to hepatitis-B virus in kidney recipients.
    Toussaint C; Cappel R; Vereerstraeten P; Kinnaert P; Dupont E; Van Geertruyden J
    Transplant Proc; 1979 Mar; 11(1):89-92. PubMed ID: 377722
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
    Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
    Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of hepatitis B surface antigenemia in cadaveric renal transplant patients.
    Rivolta E; De Vecchi A; Tarantino A; Castelnovo C; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2153-4. PubMed ID: 3274481
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
    Satterthwaite R; Ozgu I; Shidban H; Aswad S; Sunga V; Zapanta R; Asai P; Bogaard T; Khetan U; Mendez RG; Mendez R
    Transplantation; 1997 Aug; 64(3):432-5. PubMed ID: 9275109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
    Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis effect on renal graft survival (author's transl)].
    Bosković S; Grinfeld B; Jelić J
    Lijec Vjesn; 1980 May; 102(5):243-5. PubMed ID: 7003277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis B virus in a hemodialysis unit].
    Guma CL; Colombato LO; Alvarez E; Franco CO; Planes N
    Medicina (B Aires); 1985; 45(5):491-5. PubMed ID: 3842456
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.
    Fong TL; Bunnapradist S; Jordan SC; Cho YW
    Transplantation; 2002 Jan; 73(1):85-9. PubMed ID: 11792984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in response to hepatitis B virus. III. Responses to HBV and sex of donor and recipient in kidney and bone marrow transplantation.
    London WT
    Arthritis Rheum; 1979 Nov; 22(11):1267-73. PubMed ID: 389250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBsAg(+) donor as a kidney transplantation deceased donor.
    Wei HK; Loong CC; King KL; Wu CW; Lui WY
    Transplant Proc; 2008 Sep; 40(7):2097-9. PubMed ID: 18790163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of cadaveric kidneys from donors with reactive hepatitis C virus antibody or reactive hepatitis B core antibody.
    Abrams J; Nathan HM; Brayman K; Aradhye S
    Transplant Proc; 1997 Dec; 29(8):3674-6. PubMed ID: 9414885
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P
    Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and end-stage renal disease.
    Hilton PJ; Michael J; Wing AJ; Jones NF; Banatvala JE
    N Engl J Med; 1980 Jul; 303(4):225-6. PubMed ID: 7383099
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of donor and recipient hepatitis B surface antigen status on liver disease and survival in renal transplant recipients.
    Chan PC; Lok AS; Cheng IK; Chan MK
    Transplantation; 1992 Jan; 53(1):128-31. PubMed ID: 1733060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hepatitis B antigenemia on long-term success and hepatic disease in renal transplant recipients.
    Berne TV; Fitzgibbons TJ; Silberman H
    Transplantation; 1977 Dec; 24(6):412-5. PubMed ID: 339436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of hepatitis B infection on the outcome of renal allotransplantation.
    Flagg GL; Silberman H; Takamoto SK; Berne TV
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2155-8. PubMed ID: 3547916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.